Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-22-017905
Filing Date
2022-08-30
Accepted
2022-08-30 16:05:52
Documents
12
Period of Report
2022-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A me-20220815.htm   iXBRL 8-K/A 61922
  Complete submission text file 0000950170-22-017905.txt   190565

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220815.xsd EX-101.SCH 2465
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220815_lab.xml EX-101.LAB 18446
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220815_pre.xml EX-101.PRE 11478
6 EXTRACTED XBRL INSTANCE DOCUMENT me-20220815_htm.xml XML 5714
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 001-39587 | Film No.: 221214558
SIC: 2834 Pharmaceutical Preparations